Wilex AG. (4/25/16). "Press Release: Wilex AG Successfully Completes Capital Increase". Munich. |
2016-04-25 |
Ionicon Analytik GmbH. (4/22/16). "Press Release: Ionicon Launches Autosampler for High Throughput PTR-MS Measurements". Innsbruck. |
2016-04-22 |
Novartis AG. (4/21/16). "Press Release: Novartis Delivered Solid Q1 Despite Gleevec Loss of Exclusivity, Investing Behind New Launches for Long-term Growth". Basel. |
2016-04-21 |
Ablynx N.V.. (4/21/16). "Press Release: Ablynx to Receive an €8 Million Milestone as Boehringer Ingelheim Starts a Phase I Study with an anti-CX3CR1 Nanobody". Ghent & Ingelheim. |
2016-04-21 |
MorphoSys AG. (4/21/16). "Press Release: MorphoSys Provides Update on Results From Partner's Phase 2b/3 RESILIENT Study of Bimagrumab. Bimagrumab Did Not Meet Its Primary Endpoint in Patients with sIBM". |
2016-04-21 |
Aptuit, LLC. (4/21/16). "Press Release: Aptuit Announces Acquisition of Exquiron Biotech AG". Greenwich, CT. |
2016-04-21 |
Illumina, Inc.. (4/21/16). "Press Release: Illumina Files Patent Infringement Suit in Switzerland against Genoma SA for Infringement of NIPT Patents". San Diego, CA. |
2016-04-21 |
SMS-Oncology (Specialized Medical Services-Oncology B.V.). (4/21/16). "Press Release: €8.3 Million EU Grant Awarded to International »PRECIOUS« Consortium to Integrate Nanomedicines and Immunotherapy to Attack Cancer". |
2016-04-21 |
F-Star Biotechnology Ltd.. (4/21/16). "Press Release: F-star to Present at Key Conferences in April and May 2016". Cambridge. |
2016-04-21 |
iTeos Therapeutics S.A.. (4/21/16). "Press Release: €8.3 Million EU Grant Awarded to International »PRECIOUS« Consortium to Integrate Nanomedicines and Immunotherapy to Attack Cancer". Bilthoven. |
2016-04-21 |
Second Genome, Inc.. (4/20/16). "Press Release: Second Genome Secures $42.6 Million in Series B Financing Led by Pfizer Venture Investments and Roche Venture Fund". South San Francisco, CA. |
2016-04-20 |
Formycon AG. (4/20/16). "Press Release: Formycon Ends 2015 Fiscal Year with Successful Results [Not for USA, Canada, Australia, Japan, et al.]". Munich. |
2016-04-20 |
Saphetor S.A.. (4/20/16). "Press Release: Saphetor Signs Collaboration with Lausanne University Hospital (CHUV)". Lausanne. |
2016-04-20 |
Enterome Bioscience S.A.. (4/20/16). "Press Release: Enterome Raises €14.5 Million in Series C Financing Round. Nestlé Health Science Invests alongside Existing Investors". Paris & Boston, MA. |
2016-04-20 |
R-Biopharm AG. (4/19/16). "Press Release: R-Biopharm AG to Collaborate with HMNC Brain Health on Complementary Diagnostic Test for Optimization of Depression Treatment". Darmstadt. |
2016-04-19 |
G-Therapeutics B.V.. (4/19/16). "Press Release: G-Therapeutics Raises EUR 36 Million to Develop Novel Neuro-stimulation Therapy for Spinal Cord Injury". Eindhoven & Lausanne. |
2016-04-19 |
Gimv. (4/19/16). "Press Release: Gimv Invests EUR 6 Million in G-Therapeutics as Part of a Total Series A Financing of EUR 26 Million". |
2016-04-19 |
Roche. (4/19/16). "Press Release: Roche Reports Solid Sales Growth in the First Quarter of 2016. Group Sales up 4%1 at Constant Exchange Rates, 5% in Swiss Francs". Basel. |
2016-04-19 |
Evotec AG. (4/19/16). "Press Release: Evotec and Pierre Fabre Sign Multi-year Compound Management Agreement". Hamburg. |
2016-04-19 |
ProBioGen AG. (4/19/16). "Press Release: ProBioGen and Eucodis Sign Agreement to Commercialize C-LiNK, a Novel Antibody Drug Conjugation Technology". Berlin & Vienna. |
2016-04-19 |
Analytik Jena AG. (4/19/16). "Press Release: Analytik Jena Sells Site in Eisfeld. New Investor Acquiring Entire Optics Business Unit as Well as Component Production for Analytical Technology". Jena & Eisfeld. |
2016-04-19 |
MorphoSys AG. (4/18/16). "Press Release: MorphoSys Licensing Partner GSK Starts Phase 2 Study with GSK3196165 (MOR103) in Hand Osteoarthritis". |
2016-04-18 |
Oxford BioTherapeutics Ltd.. (4/18/16). "Press Release: Boehringer Ingelheim Exercises Option on Second Oncology Target Using Oxford BioTherapeutics’ OGAP System". Oxford. |
2016-04-18 |
Promethera Biosciences S.A.. (4/18/16). "Press Release: Promethera Biosciences Acquires Key Assets of Cytonet to Create the Global Leader in Regenerative Medicine and Cell Therapy for Liver Diseases". Mont-Saint-Guibert. |
2016-04-18 |
Agena Bioscience, Inc.. (4/18/16). "Press Release: Agena Bioscience Launches High Sensitivity and Multiplexed Genetic Testing Product for Targeted Analysis of Solid Tumors". San Diego, CA. |
2016-04-18 |
Euronext N.V.. (4/15/16). "Press Release: Euronext Welcomes Swiss Biotechnology Pioneer GeNeuro to Paris Market. Raises €33 Million, Market Capitalisation Totals €190 Million". Paris. |
2016-04-15 |
WuXi AppTec. (4/15/16). "Press Release: WuXi AppTec Acquires Crelux". Munich. |
2016-04-15 |
BioKryo GmbH. (4/15/16). "Press Release: BioKryo GmbH Obtains the American Association of Blood Banks (AABB) Accreditation". |
2016-04-15 |
Agena Bioscience, Inc.. (4/14/16). "Press Release: Agena Bioscience and Horizon Discovery to Launch iPLEX Reference Standards for the MassARRAY System". San Diego, CA & Cambridge. |
2016-04-14 |
GeNeuro S.A.. (4/14/16). "Press Release: GeNeuro Sets Offer Price at €13 per Share [Not for Australia, Canada or Japan]". Geneva. |
2016-04-14 |
Qiagen N.V.. (4/14/16). "Press Release: Qiagen Launches Streamlined Bioinformatics for RNA Sequencing of Liquid Biopsies. RNA-seq Explorer Solution Generates Clear Insights for Cancer »Omics« Analyses". Hilden & Germantown, MD. |
2016-04-14 |
Kymab Ltd.. (4/14/16). "Press Release: Kymab Appoints Leaders in Immuno-Oncology, Infectious Disease and Blood Disorders". Cambridge. |
2016-04-14 |
Epigenomics AG. (4/13/16). "Press Release: Epigenomics Receives FDA Approval for Epi proColon". Berlin & Germantown, MD. |
2016-04-13 |
Qiagen N.V.. (4/13/16). "Press Release: Qiagen Partners to Develop Novel Companion Diagnostic in Lung Cancer. Collaboration with Mirati Therapeutics Targets MET Gene Mutations to Personalize Treatment". Hilden & Germantown, MD. |
2016-04-13 |
Evolva Holding S.A.. (4/13/16). "Press Release: Evolva Proposes Gerard Hoetmer as New Board Member". |
2016-04-13 |
Tecan Group Ltd.. (4/13/16). "Press Release: Annual General Meeting 2016 – Tecan Shareholders Endorse All Motions Proposed by the Board of Directors". Männedorf. |
2016-04-13 |
Curetis N.V.. (4/12/16). "Press Release: Curetis Publishes Full-year 2015 Financial Results and Introduces 2016 Guidance". Amsterdam & Holzgerlingen. |
2016-04-12 |
Forbion Capital Partners. (4/12/16). "Press Release: Forbion Closes Third Life Sciences Fund, FCF III, Raising over USD200M". Naarden & Munich. |
2016-04-12 |
KWS Saat SE. (4/12/16). "Press Release: KWS to Fully Focus on Hybrid Potato Breeding and Divest its Conventional Seed Potato Business". |
2016-04-12 |
Numares AG. (4/12/16 [ca.]). "Press Release: CEO Dr. Volker Pfahlert Presented Numares at the 15th Annual Needham Healthcare Conference". |
2016-04-12 |
STAT-Diagnostica & Innovation S.L.. (4/11/16). "Press Release: STAT-Diagnostica Announces 25 Million Euros in Series C Financing Led by Gilde Healthcare. Funding Will Be Used to Accelerate Go-to-Market Strategy". Barcelona. |
2016-04-11 |
Genedata AG. (4/11/16). "Press Release: Genedata Announces the Release of Genedata Bioprocess – New Workflow Platform for Biopharmaceutical Development". Basel. |
2016-04-11 |
Bruker Corporation. (4/11/16). "Press Release: Bruker Introduces Important MALDI Biotyper Enhancements at ECCMID 2016 – New Disposable MBT Biotargets 96, MBT Subtyping and Carbapenem Resistance Tests". Amsterdam. |
2016-04-11 |
Evolva Holding S.A.. (4/11/16). "Press Release: Evolva to Co-develop Next-generation Materials with US Navy". |
2016-04-11 |
Nordic Nanovector ASA. (4/11/16). "Press Release: Nordic Nanovector Enters Collaboration with Paul Scherrer Institute to Develop New Antibody Radionuclide Conjugates for Treating Leukaemias". Oslo. |
2016-04-11 |
Boehringer Ingelheim. (4/7/16). "Press Release: Giotrif (afatinib) Approved in Europe as New Oral Treatment Option for Patients with Squamous Cell Carcinoma of the Lung". Ingelheim. |
2016-04-07 |
Kiadis Pharma N.V.. (4/7/16). "Press Release: Kiadis Pharma Proposes Robert Soiffer and Berndt Modig as Its New Supervisory Board Members". Amsterdam. |
2016-04-07 |
MorphoSys AG. (4/7/16). "Press Release: MorphoSys and Galapagos Initiate Phase 1 Study in Joint Antibody Program MOR106". |
2016-04-07 |
Analytik Jena AG. (4/7/16). "Press Release: Analytik Jena Launches a New Model for the PlasmaQuant PQ 9000 Series of ICP-OES Instruments". Jena. |
2016-04-07 |
High-Tech Gründerfonds Management GmbH. (4/7/16). "Press Release: Cunesoft Receives a Seven-digit Series-A Financing from Occident Group, High-Tech-Gruenderfonds and Bayern Kapital". |
2016-04-07 |
BioSilta Ltd.. (4/6/16). "Press Release: BioSilta Ltd Acquires Worldwide Rights to CyDisCo Technology from University of Oulu to Produce Proteins with Multi-industry Applications". Cambridge. |
2016-04-06 |
Lumos Pharma. (4/6/16). "Press Release: Lumos Pharma Raises $34 Million in Series B Financing". Austin, TX. |
2016-04-06 |
Thermosome GmbH. (4/6/16). "Press Release: Thermosome Receives €2.7m Research Grant from the German Federal Ministry of Education and Research (BMBF)". Martinsried. |
2016-04-06 |
Thermosome GmbH. (4/6/16). "Press Release: Thermosome Raises €4.6m with First financing Round and a Research Grant from the German Government". Martinsried. |
2016-04-06 |
Pressure BioSciences, Inc.. (4/6/16). "Press Release: Company Reports Increases in Total/Products/Grant Revenue & Product Gross Margins". South Easton, MA. |
2016-04-06 |
Meiogenix S.A.S.. (4/6/16). "Press Release: Meiogenix Announces a Licensing Agreement with Bayer to Apply SpiX Technology in Crops". Paris. |
2016-04-06 |
Merck KGaA. (4/6/16). "Press Release: Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy Test for Colorectal Cancer Patients". Darmstadt. |
2016-04-06 |
Bruker Corporation. (4/6/16). "Press Release: The Weizmann Institute of Science Selects Bruker GigaHertz NMR Technology to Enable Advanced Structural Biology Research". Rehovot & Billerica, MA. |
2016-04-06 |
Markes International Ltd.. (4/5/16). "Press Release: New Paper in Analytical Chemistry – Select-eV Unravels the Composition of Complex Motor Oils". |
2016-04-05 |
Evolva Holding S.A.. (4/5/16). "Press Release: Evolva Gains Exclusive License to Develop and Commercialise Nootkatone Globally for Pest Control". |
2016-04-05 |
Qiagen N.V.. (4/5/16). "Press Release: Qiagen Partners with IT Leaders on Novel Infrastructure for Genomics". Boston, MA & Hilden. |
2016-04-05 |
Proteome Sciences plc. (4/5/16). "Press Release: Deep Protein Profiling Key to Improving Cancer Treatment". Cobham. |
2016-04-05 |
Metabomed Ltd.. (4/4/16). "Press Release: Cancer Metabolism Company Metabomed Completes $18 Million Series A Financing". Yavne. |
2016-04-04 |
Anergis S.A.. (4/4/16). "Press Release: Anergis Closes CHF 5 Million Financing Round Extension to Conduct Large-Scale ATIBAR Trial with Ultra-Fast Allergy Immunotherapy AllerT". Epalinges. |
2016-04-04 |
Boehringer Ingelheim. (4/4/16). "Press Release: Interim Phase III Data Show Praxbind (Idarucizumab) Reverses Dabigatran (Pradaxa) in Emergency Situations". Ingelheim. |
2016-04-04 |
Agena Bioscience, Inc.. (4/4/16). "Press Release: Agena Bioscience Launches In Vitro Diagnostic Tests for Lung and Colon Cancer in Europe. Company Achieves CE-IVD mark and Enters Routine Molecular Diagnostics Market". San Diego, CA & Hamburg. |
2016-04-04 |
MorphoSys AG. (4/4/16). "Press Release: Ad hoc – MorphoSys Sues Janssen Biotech and Genmab for Patent Infringement". |
2016-04-04 |
Medigene AG. (4/4/16). "Press Release: Medigene Sells Partial Stake in Immunocore". Martinsried. |
2016-04-04 |
Stratec Biomedical AG. (4/1/16). "Press Release: Stratec Completes Acquisition of Diatron". Birkenfeld. |
2016-04-01 |
Medigene AG. (4/1/16). "Press Release: Medigene Announces Start of Phase II Trial with DC Vaccines and Upcoming Milestone Payment". Martinsried. |
2016-04-01 |
Endress+Hauser AG. (4/1/16). "Press Release: Endress+Hauser Completes Takeover of Analytik Jena. Remaining Minority Shareholders Receive Cash Compensation". |
2016-04-01 |
Bristol-Myers Squibb Company. (4/1/16). "Press Release: Bristol-Myers Squibb Completes Previously Announced Acquisition of Padlock Therapeutics, Inc.". New York, NY. |
2016-04-01 |
Biogen Inc.. (4/1/16). "Press Release: Flixabi, an Infliximab Biosimilar Candidate Referencing Remicade, Receives Positive CHMP Opinion". Zug. |
2016-04-01 |
Novartis AG. (3/31/16). "Press Release: Novartis Publishes Updated 2015 Segment Financials Reflecting New Division Structure". Basel. |
2016-03-31 |
Roche. (3/31/16). "Press Release: Roche to Initiate Testing for Zika Virus at U.S. Blood Centres under FDA Investigational New Drug Application Protocol". Basel. |
2016-03-31 |
Fusion Antibodies Ltd.. (3/31/16). "Press Release: Fusion Antibodies and MAB Discovery Announce Project Collaboration". |
2016-03-31 |
Thermo Fisher Scientific Inc.. (3/31/16). "Press Release: Thermo Fisher Scientific Completes Acquisition of Affymetrix Following Approval of Transaction by Affymetrix Stockholders". Waltham, MA & Santa Clara, CA. |
2016-03-31 |
Amal Therapeutics S.A.. (3/30/16). "Press Release: Amal Therapeutics Raises CHF 3 Million in a Series A Financing Round Led by Boehringer Ingelheim Venture Fund". Geneva & Ingelheim. |
2016-03-30 |
Genohm. (3/30/16). "Press Release: Genohm Opens Its New US Branch in Durham, NC". Lausanne & Durham, NC. |
2016-03-30 |
Affimed N.V.. (3/30/16). "Press Release: Affimed Reports Financial Results for Fourth Quarter
and Year End 2015. Successful Financings Closed and US Presence Established". Heidelberg. |
2016-03-30 |
CureVac AG. (3/30/16). "Press Release: CureVac Appoints Leading Experts to Its Scientific Advisory Board". Tübingen. |
2016-03-30 |
Epigenomics AG. (3/30/16). "Press Release: Epigenomics Enters Strategic License and Development Agreement with BioChain on Novel, Blood-based Lung Cancer Test". Berlin & Germantown, MD. |
2016-03-30 |
Evolva Holding S.A.. (3/30/16). "Press Release: Evolva Publishes Financial Results for 2015 and Updates on Projects". |
2016-03-30 |
Boehringer Ingelheim. (3/30/16). "Press Release: Boehringer Ingelheim Venture Fund Invests in Amal Therapeutics to Develop Novel Therapeutic Colorectal Cancer Vaccine". Ingelheim & Geneva. |
2016-03-30 |
4SC AG. (3/30/16). "Press Release: 4SC Announces Results for Financial Year 2015". Planegg-Martinsried. |
2016-03-30 |
Editas Medicine, Inc.. (3/30/16). "Press Release: Editas Medicine Reports Fourth Quarter and Full Year 2015 Financial Results". Cambridge, MA. |
2016-03-30 |
Selexis S.A.. (3/30/16). "Press Release: Selexis SA Announces Spring 2016 Conference Schedule". Geneva. |
2016-03-30 |
Zavante Therapeutics, Inc.. (3/30/16). "Press Release: Zavante Therapeutics Closis $45 Million Series A Financing in Support of U.S. Development for a First-in-Class Injectable Antibiotic". San Diego, CA. |
2016-03-30 |
Gadeta B.V.. (3/29/16). "Press Release: Gadeta Closes EUR 7 Million Series A Financing to Advance Novel Cancer Immunotherapies to the Clinic". Utrecht. |
2016-03-29 |
Qiagen N.V.. (3/29/16). "Press Release: Qiagen to Submit Conditional Voluntary Takeover Offer for Shares of Exiqon A/S [Not for US, CA, JP, AU, ZA, et al.]
Transaction will expand leadership position in RNA technologies". Venlo. |
2016-03-29 |
Newron Pharmaceuticals S.p.A.. (3/29/16). "Press Release: Newron Receives Complete Response Letter from US FDA for Xadago (safinamide)". Milan. |
2016-03-29 |
Metabolon, Inc.. (3/29/16). "Press Release: Metabolon and Synlab Group Form Commercialization Collaboration for Quantose IR Diagnostic". Research Triangle Park, NC. |
2016-03-29 |
Ligand Pharmaceuticals Inc.. (3/28/16). "Press Release: Ligand Enters into OmniAb Platform License Agreement with ABBA Therapeutics". San Diego, CA. |
2016-03-28 |
4SC AG. (3/24/16). "Press Release: Chairman of the Management Board Enno Spillner Will Not Extend His Current Term of Office, But Will Leave the Company After a Transitional Period Ending 30 June 2016". Planegg-Martinsried. |
2016-03-24 |
ITM Isotopen Technologien München AG. (3/24/16). "Press Release: ITM and Scil Proteins Announce New Partnership for Targeted Radio Conjugates". Garching & Halle/Saale. |
2016-03-24 |
ThromboGenics N.V.. (3/24/16). "Press Release: ThromboGenics To Present at Key Investor Meetings". Leuven. |
2016-03-24 |
Bristol-Myers Squibb Company. (3/23/16). "Press Release: Bristol-Myers Squibb to Acquire Padlock Therapeutics, Inc.". New York, NY & Cambridge, MA. |
2016-03-23 |
Probiodrug AG. (3/23/16). "Press Release: Probiodrug Appoints Mark Booth as Chief Business Officer". Halle (Saale). |
2016-03-23 |
Stratec Biomedical AG. (3/23/16). "Press Release: Stratec to Acquire Hematology System Specialist Diatron". Birkenfeld. |
2016-03-23 |
bm-t Beteiligungsmanagement Thüringen GmbH. (3/23/16). "Press Release: High-Tech Gründerfonds (HTGF) and bm|t Renew Their Cooperation Agreement". |
2016-03-23 |